Who won the CRISPR patent fight?

This week Jennifer Doudna and Emmanuelle Charpentier were awarded the Nobel Prize in chemistry for developing a process to edit DNA known as CRISPR Cas-9.

Who owns the patent on CRISPR technology?

Both UC Berkeley and the MIT-Harvard Broad Institute claimed IP rights to CRISPR-Cas9 in 2012. Since the Broad Institute paid to expedite its application, its patents were awarded first even though UC Berkeley filed first.

Are Jennifer Doudna and Emmanuelle Charpentier friends?

Church counts Doudna as a close friend, but has not yet heard from her about the prize she shares with Charpentier. “I was with her last night, virtually. I mean, you know, it’s Covid,” he said.

Did doudna discover CRISPR?

7, 2020, Jennifer Doudna and her research collaborator Emmanuelle Charpentier were awarded the Nobel Prize in Chemistry for discovering the CRISPR gene-editing technology. As she built a career as a top molecular biologist, Doudna never lost that intense curiosity about how things work in the living world.

When did Doudna and Charpentier get their patent?

Meanwhile, Doudna and Charpentier’s original CRISPR patent application from May 2012 — the application that has triggered the now ongoing dispute yet to be resolved by the U.S. Patent and Trademark Office — is still pending.

When was the first patent filed for CRISPR Cas9?

A mere few months later, in December 2012, a research group at the Broad Institute affiliated with MIT and Harvard University (the Broad Institute) also filed its first patent application for CRISPR-Cas9. [9]

What does Caribou Biosciences latest patent mean?

Now, the field is trying to figure out what Caribou Biosciences’ latest patent means. A biotech startup has been issued a patent that involves CRISPR, the breakthrough gene-editing method that has sparked a nearly unprecedented intellectual property feud between some of the country’s biggest institutions.